PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
出版年份 2016 全文链接
标题
PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-08-05
DOI
10.1038/srep30788
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway
- (2015) Shuichi Fukuda et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinicopathological Characteristics of Gynecological Cancer Associated with Hypoxia-Inducible Factor 1α Expression: A Meta-Analysis Including 6,612 Subjects
- (2015) Yue Jin et al. PLoS One
- The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer
- (2015) G.R. Leisching et al. TOXICOLOGY
- High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
- (2015) Yang Lin et al. Journal of Cancer
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions
- (2013) Xuejie Zhu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc
- (2013) K. Hatano et al. MOLECULAR CANCER RESEARCH
- Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy
- (2013) Cynthia Brito Lins Pereira et al. PLoS One
- Proteomic Identification of Neoadjuvant Chemotherapy-Related Proteins in Bulky Stage IB-IIA Squamous Cervical Cancer
- (2013) Shuangwei Zou et al. Reproductive Sciences
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB–IIA cervical cancer treated with neoadjuvant chemotherapy
- (2012) LanYing Jin et al. GYNECOLOGIC ONCOLOGY
- Hypoxia-inducible factor-1 as a therapeutic target in cancer
- (2012) Ceen-Ming Tang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China
- (2012) Yang Yuan et al. MEDICAL ONCOLOGY
- C-myc as a predictive marker for chemotherapy in metastatic breast cancer
- (2011) Nataša Todorović-Raković et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
- (2011) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
- (2010) Hua-shan Shi et al. CANCER SCIENCE
- Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
- (2010) Wenhao Guo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
- (2009) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1)in vitroandin vivoby increasing the activity of the p-glycoproteinviaactivation of p38
- (2008) Christoph Sauvant et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
- (2007) Anand Rajeswaran et al. LUNG CANCER
- Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy
- (2007) Leri S. Faried et al. MOLECULAR CARCINOGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More